Owning the Market: The Business of Listed Stock Exchanges When the house itself is on the market, investors can buy a toll‑booth that never sleeps.
The Generics Dilemma: When Cheap Becomes Costly Why Western governments are rethinking rock‑bottom drug prices in a world no longer sure of its supply chains
The $100 Genome Meets the FDA Rulebook: DNA Sequencing’s Next Act Isn’t Just About Speed or Cost The $100 genome is here, but growth stalls: regulation, reimbursement and China’s price war reshape a crowded sequencing market racing toward multi‑omics.
Rating Agenices: Can they keep growing? Can AI dethrone the Big Three credit raters? History, profits and deep data clash with new algorithms in a $7 trillion bond‑market battleground.
The Global Insurance Broker Industry: Should you bother? When Baltimore’s Key Bridge crumbled into the Patapsco River, three rival brokers choreographed billions in coverage before sunrise—proof that in a poly-crisis world, the power brokers aren’t the insurers or the reinsurers, but the middlemen who now command a US$7 trillion sea of global risk.
The global Elevator & Escalator Industry - A deep dive The worldwide elevator and escalator market is projected to expand to roughly 166 billion US‑dollars by 2028, an annualised growth rate close to six per cent from 2024. Asia‑Pacific—particularly China and India—continues to supply most of the new‑equipment demand, whereas industrialised OECD economies increasingly focus